Aethlon Medical
AEMD · NASDAQ
$5.31+$0.00 (+0.00%)TodayMarket closed ·
Prev close $5.31
Who owns AEMD
Largest institutional holders, from their latest 13F filings
The 10 largest institutions hold 2.7% of AEMD’s shares.
- Armistice Capital LLC0.6%
- HRT Financial LP0.6%
- Citadel Advisors LLC0.3%
- Jane Street Capital, L.L.C.0.3%
- Next 6 largest institutions0.9%
- All other shareholders97.3%
| Holder | Shares | % of shares |
|---|---|---|
| Armistice Capital LLC | 16.48K | 0.63% |
| HRT Financial LP | 14.55K | 0.55% |
| Citadel Advisors LLC | 8.60K | 0.33% |
| Jane Street Capital, L.L.C. | 7.78K | 0.30% |
| Shay Capital LLC | 6.21K | 0.24% |
| Virtu Americas LLC | 5.56K | 0.21% |
| Alumni Capital LP | 4.51K | 0.17% |
| Ikarian Capital LLC | 2.87K | 0.11% |
| Geode Capital Management, L.L.C. | 2.04K | 0.08% |
| Scientech Research LLC | 2.01K | 0.08% |
Largest mutual fund holders
| Holder | Shares | % of shares |
|---|---|---|
| Fidelity Extended Market Index Fund | 1.75K | 0.07% |
| Fidelity Series Total Market Index Fund | 215 | 0.01% |
Insider trades
Form 4 filings by officers, directors and large holders
Insiders made no open-market buys or sales of AEMD in the last 6 months.
| Insider | Type | Shares | Value |
|---|---|---|---|
| LAROSA STEVEN P | Award | 42.00K | — |
| FRAKES JAMES B | Award | 42.00K | — |
| Gikakis Nicolas | Tax withholding | 436 | $2.84K |
| Shah Chetan | Tax withholding | 436 | $2.84K |
| BROENNIMAN EDWARD G | Tax withholding | 218 | $1.42K |
| Gikakis Nicolas | Tax withholding | 2.18K | $1.79K |
| Shah Chetan | Tax withholding | 2.18K | $1.79K |
| BROENNIMAN EDWARD G | Tax withholding | 1.09K | $895 |
Short interest
Settled Sep 30, 2026
- Shares short
- 75.45K
- Days to cover
- 1.00
- % of shares outstanding
- 2.87%
- Average daily volume
- 8.42M
- Change since last report
- +0.8%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.